Huilin Hu

Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure

S. Boonen, I. Reid, P. Delmas, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD.

K. Chung, H. Worth, J. Felser, 2011, Respiratory medicine.

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

S. Cummings, S. Boonen, J. Cauley, 2007, The New England journal of medicine.

Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture

S. Boonen, C. Pieper, J. Magaziner, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer

P. Fasching, T. Delea, J. O’Shaughnessy, 2021, Cancer management and research.

Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data

E. Kerwin, M. Decramer, K. Chapman, 2015, International journal of chronic obstructive pulmonary disease.

Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2 − Advanced Breast Cancer

J. O’Shaughnessy, D. Chandiwana, Huilin Hu, 2021 .

Impact of ribociclib (RIB) dose modifications (mod) on overall survival (OS) in patients (pts) with HR+/HER2- advanced breast cancer (ABC) in MONALEESA(ML)-2.

P. Neven, A. Bardia, L. Hart, 2022, Journal of Clinical Oncology.